Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 3Breast 2

Conditions

Neoplasms 3

Interventions

Paclitaxel 57Gemcitabine 51Carboplatin 51Surveys and Questionnaires 48Docetaxel 37Bevacizumab 37pembrolizumab 33Nivolumab 29Cisplatin 28Fluorouracil 24Capecitabine 23Irinotecan 22Erlotinib Hydrochloride 22Sorafenib 20Leucovorin 19Afatinib 19Radiotherapy 18Pemetrexed 18Oxaliplatin 17Trastuzumab 16Ipilimumab 15regorafenib 14Blood Specimen Collection 14130-nm albumin-bound paclitaxel 14olaparib 13Interviews as Topic 13Cetuximab 13Albumin-Bound Paclitaxel 13atezolizumab 12Sunitinib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Caregivers × Tumor-Agnostic × Clear all
NCT00675467 2016-04-08

Palliative Care and Symptom Management for the Pediatric Oncology Patient

M.D. Anderson Cancer Center

Completed
13 enrolled
Tumor-Agnostic

Neoplasms

NCT00938769 2014-02-07

Enhanced Self-Efficacy Training

Duke University

Phase NA Completed
358 enrolled
Tumor-Agnostic

Neoplasms

NCT01432431 2013-09-05

Spiritual Care in Improving Quality of Life of Patients, Caregivers, and Hospital Staff

City of Hope Medical Center

Phase NA Completed
100 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡